Chemoinformaics analysis of 3-Methyldec-4-en-1-ol
Molecular Weight | 170.296 | nRot | 7 |
Heavy Atom Molecular Weight | 148.12 | nRig | 1 |
Exact Molecular Weight | 170.167 | nRing | 0 |
Solubility: LogS | -4.128 | nHRing | 0 |
Solubility: LogP | 3.527 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 33.8414 |
nHD | 1 | BPOL | 22.0706 |
QED | 0.459 |
Synth | 2.935 |
Natural Product Likeliness | 2.385 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.006 |
HIA | 0.022 |
CACO-2 | -4.309 |
MDCK | 0.0000345 |
BBB | 0.974 |
PPB | 0.967899 |
VDSS | 2.941 |
FU | 0.0312503 |
CYP1A2-inh | 0.687 |
CYP1A2-sub | 0.815 |
CYP2c19-inh | 0.156 |
CYP2c19-sub | 0.374 |
CYP2c9-inh | 0.122 |
CYP2c9-sub | 0.909 |
CYP2d6-inh | 0.019 |
CYP2d6-sub | 0.523 |
CYP3a4-inh | 0.089 |
CYP3a4-sub | 0.175 |
CL | 5.399 |
T12 | 0.679 |
hERG | 0.013 |
Ames | 0.005 |
ROA | 0.056 |
SkinSen | 0.538 |
Carcinogencity | 0.043 |
EI | 0.987 |
Respiratory | 0.048 |
NR-Aromatase | 0.009 |
Antiviral | No |
Prediction | 0.745363 |